Health


 Beam Maintains Cash Position Despite Current Burn Rate

Beam Maintains Cash Position Despite Current Burn Rate

September 04, 2024 11:32 AM PDT| By Team Kalkine Media

Beam Therapeutics, operating within the,Healthcare sector,, has recently addressed concerns regarding its financial stability amid its current cash burn rate. As a company focused on advancing gene-editing therapies, Beam Therapeutics has provided re...

 Exciting Biotech Opportunity: Explore Viking Therapeutics for Potential Growth

Exciting Biotech Opportunity: Explore Viking Therapeutics for Potential Growth

September 03, 2024 12:17 PM PDT| By Team Kalkine Media

Headlines,Innovative Research:,Viking Therapeutics has shown significant potential with its promising weight loss treatment, VK2735, which is advancing to phase 3 trials.,Strong Financial Position,: The company boasts a robust financial standing with...

 Amneal Pharmaceuticals Surges 29% Amid Key FDA Approvals and Strong Q2 Performance

Amneal Pharmaceuticals Surges 29% Amid Key FDA Approvals and Strong Q2 Performance

September 03, 2024 12:14 PM PDT| By Team Kalkine Media

Headlines,Amneal Pharmaceuticals' shares rose 29% in the past month following multiple FDA approvals, including a novel Parkinson's disease treatment.,The company achieved robust revenue growth in Q2 2024, driven by new product launches and increased...

 Two Resilient Dividend Payers for Economic Uncertainty

Two Resilient Dividend Payers for Economic Uncertainty

September 02, 2024 04:41 PM PDT| By Team Kalkine Media

Headlines,Healthcare's Resilience: AbbVie and Merck, two prominent pharmaceutical companies, are well-positioned to navigate economic downturns due to their essential products and robust pipelines.,AbbVie's Strategic Growth: AbbVie continues to perfo...

 Cathie Wood's Strategic Moves: 3 Companies She Invested In

Cathie Wood's Strategic Moves: 3 Companies She Invested In

August 30, 2024 12:34 PM PDT| By Team Kalkine Media

Headlines,Cathie Wood recently expanded her positions in Tempus AI, Blade Air Mobility, and Absci, signaling her focus on innovative technologies in healthcare and transportation.,Tempus AI has shown strong growth since its IPO, with a promising futu...

 Alphatec Faces Challenges Despite Positive Sentiment

Alphatec Faces Challenges Despite Positive Sentiment

August 30, 2024 08:26 AM PDT| By Team Kalkine Media

In recent developments within the,healthcare sector,, Alphatec Holdings, Inc. continues to grapple with challenges, despite experiencing some positive sentiment. The company's current financial and operational situation has attracted attention as it...

 Globus Medical Reports Positive Financial Results

Globus Medical Reports Positive Financial Results

August 30, 2024 08:23 AM PDT| By Team Kalkine Media

In recent developments within the,healthcare sector,, Globus Medical, Inc. has announced a significant financial performance update. The company’s recent financial results have shown promising performance, reflecting positively on its operations and...

 How GeneDx Manages Debt and Its Financial Impact

How GeneDx Manages Debt and Its Financial Impact

August 29, 2024 06:13 PM PDT| By Team Kalkine Media

In the,healthcare sector,, GeneDx Holdings, a company specializing in genetic and genomic testing services, is under scrutiny regarding its use of debt. Recent assessments focus on whether the company is managing its debt obligations effectively and...

 Recent Developments In this Stock Capture Attention

Recent Developments In this Stock Capture Attention

August 29, 2024 10:30 AM PDT| By Team Kalkine Media

Koru Medical Systems, operating within the,healthcare sector,, focuses on the development of innovative infusion therapies. Recent updates related to the company's performance and strategic initiatives have garnered significant attention, reflecting...

 ADMA Biologics: Key Factors Behind Its Recent Price Surge

ADMA Biologics: Key Factors Behind Its Recent Price Surge

August 28, 2024 11:18 AM PDT| By Team Kalkine Media

Headlines:,ADMA Biologics' Impressive 12-Week Price Surge,Strong Short-Term Performance Highlights ADMA's Momentum,Factors Supporting ADMA Biologics' Continued Price Strength,ADMA Biologics’ Impressive 12-Week Price Surge,ADMA Biologics,(NASDAQ:ADMA)...

 MediciNova Inc. Poised for Advancement Among Biotech Peers

MediciNova Inc. Poised for Advancement Among Biotech Peers

August 28, 2024 10:44 AM PDT| By Team Kalkine Media

In the,Healthcare sector,, MediciNova Inc. stands out due to its positioning within the industry. The company, which specializes in the development of novel therapies for serious medical conditions, is seen as well-positioned for future advancements...

 Hain Celestial Sees Sales Drop in FY 2024, but Profit Margins Improve Amid Cost Management Efforts

Hain Celestial Sees Sales Drop in FY 2024, but Profit Margins Improve Amid Cost Management Efforts

August 27, 2024 10:47 PM PDT| By Team Kalkine Media

Hain Celestial Group (Nasdaq: HAIN), a prominent global health and wellness company known for its commitment to promoting healthier living through its better-for-you brands, has announced its financial results for the fourth quarter and fiscal year e...

 Here’s Zimmer Biomet Debt Usage

Here’s Zimmer Biomet Debt Usage

August 27, 2024 12:25 PM PDT| By Team Kalkine Media

Zimmer Biomet Holdings, a major entity in the,healthcare sector,, has recently attracted attention for its management of debt. Traded under the ticker ZBH, the company’s approach to utilizing debt is under scrutiny, particularly regarding how it impa...

 Mettler-Toledo International's Recent Performance: A Healthcare Sector Review

Mettler-Toledo International's Recent Performance: A Healthcare Sector Review

August 27, 2024 12:21 PM PDT| By Team Kalkine Media

Mettler-Toledo International Inc., a key player in the,Healthcare sector,, has recently attracted attention due to its performance trends. Traded under the ticker MTD, the company’s market position and operational challenges are under review, reflect...

 Industry Veteran Joins Pearsanta Inc. as President

Industry Veteran Joins Pearsanta Inc. as President

August 26, 2024 11:52 AM PDT| By Team Kalkine Media

Headlines,Pearsanta Inc. Appoints New President,Christopher Mitton Brings Decades of Expertise to Pearsanta,Aditxt’s Subsidiary Accelerates Precision Health with New Leadership,Aditxt,(NASDAQ:ADTX),, a platform dedicated to advancing health innovatio...

 Medtronic Achieves Key Milestones, Strengthening Market Position

Medtronic Achieves Key Milestones, Strengthening Market Position

August 26, 2024 12:00 AM PDT| By Team Kalkine Media

In the,healthcare sector,, Medtronic has announced recent developments that have garnered attention from the market. The company's latest updates highlight significant progress and improvements in its business operations. These advancements are contr...

 This Undervalued Stock Could Compete with Eli Lilly for $1 Trillion Valuation

This Undervalued Stock Could Compete with Eli Lilly for $1 Trillion Valuation

August 22, 2024 11:17 PM PDT| By Team Kalkine Media

Eli Lilly is gaining significant attention as its market capitalization approaches $1 trillion, driven largely by optimism surrounding its anti-obesity drugs. This surge in interest may overshadow other pharmaceutical companies creating opportunities...

 Zepp Health Cuts Losses, Embraces AI Innovation

Zepp Health Cuts Losses, Embraces AI Innovation

August 22, 2024 10:41 AM PDT| By Team Kalkine Media

Headlines,Zepp Health Boosts Margins with AI and New Tech,Zepp Health's Gross Margins Hit Record High,Zepp Health Plans Exciting Product Launches and Tech Upgrades,Zepp Health Corporation,(NYSE:ZEPP),revealed its second-quarter 2024 results, showing...

 Comparing Merck and AbbVie: A Detailed Look

Comparing Merck and AbbVie: A Detailed Look

August 22, 2024 01:03 AM PDT| By Team Kalkine Media

Headlines,Merck Outpaces AbbVie in Revenue Growth,Merck's Superior Profitability and Stability in Pharma,Merck,(NYSE:MRK),has shown strong gains, with its stock price increasing by 65% from early 2021 to around $115 today. However, AbbVie has outperf...

 Eli Lilly's Strong Q2 Performance: What's Ahead?

Eli Lilly's Strong Q2 Performance: What's Ahead?

August 14, 2024 08:40 AM PDT| By Team Kalkine Media

Headlines,Solid Q2 Results: Eli Lilly surpassed expectations with $11.3 billion in revenue and adjusted earnings of $3.92 per share, prompting a 15% rise in its stock price.,Exceptional Performance: The stock has seen a 455% increase since January 20...

Recent Articles






Investing Tips

Previous Next